Early Successes Hint at Big Payoff, But the Road to New Drugs Is Long
Robert F. Service
With researchers racing to set up structural genomics efforts in both academia and industry, two unanswered questions loom over the field. How well will this highly experimental approach work? And will it lead to the development of new drugs?